Alibaba Health Information Technology Limited
0241.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.26B
Close$
$1.55
45.6% downside
Current Fair Value
45.6% downsideOvervalued by 45.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $46.26 Billion |
|---|---|
| Enterprise Value | $41.44 Billion |
| Dividend Yield | $0.22 (7.86%) |
| Earnings per Share | $0.12 |
| Beta | 1.61 |
| Outstanding Shares | 16,195,904,998 |
Return
| Return on Equity | 8.42% |
|---|---|
| Return on Assets | 6.51% |
| Return on Invested Capital | 8.84% |
Valuation & Multiples
| P/E Ratio | 20.41 |
|---|---|
| PEG | 20.78 |
| Price to Sales | 1.43 |
| Price to Book Ratio | 2.85 |
| Enterprise Value to Revenue | 1.15 |
| Enterprise Value to EBIT | 26.14 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
December 1, 2026
EPS Estimate
$0.08
Average shareholder expectationRevenue Estimate
$21.03 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Alibaba Health Information Technology Limited
1,394 employees
CEO: Shunyan Zhu Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong....